Tag Archives: cognition

The Drugs That Keep On Giving? 
Study Finds Unexpected Neuroprotective Benefits Of GLP-Agonists 

The Drugs That Keep On Giving? Study Finds Unexpected Neuroprotective Benefits Of GLP-1 Agonists 

In the ever-evolving landscape of medical science, certain discoveries stand out not just for their initial impact, but for their ability to continually reveal new and unexpected benefits. Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) stand as prime examples of such pharmaceutical revelations. Initially developed for diabetes management and then repurposed for obesity treatment, these versatile compounds are now capturing attention for their potential cognitive benefits, further expanding their already impressive repertoire of clinical applications.

As the medical community increasingly focuses on brain health as a cornerstone of longevity, GLP-1 agonists have emerged as surprising contenders from an unexpected corner of pharmacology. This class of drugs, exemplified by semaglutide (marketed as Ozempic and Wegovy), challenges the conventional understanding of the intricate connections between metabolic health and cognitive longevity.

This latest chapter in the GLP-1 agonist saga is particularly significant given the growing concern over age-related cognitive decline and neurodegenerative diseases in an aging population. While lifestyle interventions such as diet and exercise remain foundational for brain health, the potential cognitive benefits of GLP-1 agonists represent an exciting new frontier in pharmacological approaches to healthy aging.

Continue reading

The Connection Between Aging, Cognitive Performance, and Oxidative Stress

Cognitive performance is a critical capability that allows individuals to function accordingly in their everyday lives; it provides humans with the capacity for sustenance and self-preservation and the free will to engage in activities of their choice. However, many researchers have posed a question regarding the sustainability of the human body’s cognitive performance, particularly because cognition may not be an all-enduring ability and is subject to different levels of degradation.

Several studies have proposed this concept, and research shows that several factors could affect a person’s cognitive ability, along with the discovery that multiple types of cognition correlate to specific functionality in the human body.

After several assessments of this proposed thesis, oxidative stress was considered one of the most significant factors correlated to a decrease in cognitive performance. This type of degradation is associated with the inherent decline of the body – aging.

Continue reading

The Cognitive Complications of COVID-19

At this time, the long-term complications of COVID-19 remain unknown although there is evidence of changes aside from acute symptoms referred to as “long COVID.” Several case studies have reported neurological problems in severely affected COVID-19 patients – such complications may arise from associated stroke, inflammatory syndrome, immune responses, and other health factors.

Currently, there is little clinical information concerning the nature and prevalence of cognitive consequences post-COVID infection, the full spectrum of their severity, or the connection between hospitalization status. Emerging evidence points to potential cognitive deficits associated with the virus, revealing significant brain function impacts in the worst cases of infection, according to a recent non-peer-reviewed study.

Cognitive Performance in COVID-19 Survivors

Led by Imperial College London doctor, Adam Hampshire, the study encompassed a cohort of over 84,000 participants who performed cognitive tests aimed at assessing brain performance, including word recall and puzzles. Data for analysis was gathered from the Great British Intelligence Test. The research team controlled results for age, gender, education level, income, racial-ethnic group, and pre-existing medical conditions.

The study revealed that participants who recovered from suspected or confirmed COVID-19 performed worse on cognitive tests in multiple domains than expected given their age and demographic profiles. Observed cognitive defects were of “substantial effect size,” especially among individuals who had been hospitalized with COVID-19. Furthermore, deficits scaled with symptom severity with the worst cases of illness showing a cognitive impact equivalent to a 10-year decline in global performance in patients aged between 20 and 70 years.

“Our analyses … align with the view that there are chronic cognitive consequences of having COVID-19,” the researchers wrote in a report of their findings. “People who had recovered, including those no longer reporting symptoms, exhibited significant cognitive deficits.”

Study Limitations

Hampshire and his team’s results are worrisome, however, their findings are yet to be reviewed by other researchers. Experts warn that the latest results should be interpreted with caution as the cognitive health of participants pre-COVID infection was not known or accounted for in the study. In addition, the study’s findings do not reflect long-term recovery, indicating that the cognitive effects may only be present for the short term. Study’s findings can not be entirely reliable as they do not compare before and after scores, involved a large number of people who self-reported having COVID-19 with no positive test measure

Nonetheless, the latest study alongside other emerging research on the potential cognitive repercussions of COVID-19 illness add to a growing list of concerns. While current literature signals potential for cognitive complications, it warrants further investigation and understanding of the duration of such cognitive deficits. Forthcoming studies should aim to identify the extent to which cognition is affected after infection and whether permanent neurological damage to brain function is possible.